Valganciclovir is a Oral For Solution in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Valganciclovir Hydrochloride.
| Product ID | 59651-444_1e08a87f-624a-4993-a773-8c660c27b6af |
| NDC | 59651-444 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Valganciclovir |
| Generic Name | Valganciclovir Hydrochloride Powder, |
| Dosage Form | For Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-11-17 |
| Marketing Category | ANDA / |
| Application Number | ANDA215124 |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | VALGANCICLOVIR HYDROCHLORIDE |
| Active Ingredient Strength | 50 mg/mL |
| Pharm Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-11-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0603-6330 | Valganciclovir | Valganciclovir hydrochloride |
| 0904-6796 | Valganciclovir | Valganciclovir |
| 16714-765 | Valganciclovir | Valganciclovir |
| 27241-158 | Valganciclovir | Valganciclovir |
| 31722-832 | Valganciclovir | Valganciclovir |
| 31722-837 | VALGANCICLOVIR | VALGANCICLOVIR HYDROCHLORIDE |
| 42291-875 | Valganciclovir | Valganciclovir hydrochloride |
| 48433-124 | Valganciclovir | Valganciclovir |
| 50268-787 | Valganciclovir | Valganciclovir |
| 55111-762 | Valganciclovir | Valganciclovir |
| 59651-444 | Valganciclovir | Valganciclovir hydrochloride powder, |
| 60429-846 | Valganciclovir | Valganciclovir |
| 63629-2288 | Valganciclovir | Valganciclovir hydrochloride |
| 63739-076 | Valganciclovir | Valganciclovir |
| 64380-153 | Valganciclovir | Valganciclovir hydrochloride |
| 68084-965 | Valganciclovir | Valganciclovir |
| 69097-277 | Valganciclovir | Valganciclovir |
| 0004-0038 | Valcyte | valganciclovir |